Bruker Corporation Stock Analysis & AI Score
Bruker Corporation (BRKR) has an ST Score of 57.8 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $59.50 price target (-7.0% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Bruker Corporation (BRKR) has an ST Score of 57.8 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $59.50 price target (-7.0% downside).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthD+
All factor grades
- SentimentA+
- ProfitabilityA
- MomentumA-
- ForecastC+
- GrowthC
- ValuationD+
- Financial StrengthD+
- Piotroski5/9
Contact
BRKR stock: frequently asked questions
What is BRKR's ST Score?
Bruker Corporation (BRKR) has an ST Score of 57.8 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BRKR a buy, hold, or sell?
Analysts rate BRKR a Buy, with a price target of $59.50 (-7.0% vs the current price). Our ST Score grades it B- (57.8/100). The ST Score is a data-driven signal, not a recommendation.
What are BRKR's factor grades?
Valuation D+, Profitability A, Financial Strength D+, Momentum A-, Growth C, Forecast C+, Sentiment A+.
What is BRKR's valuation grade?
Bruker Corporation (BRKR) earns a valuation grade of D+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BRKR's growth grade?
Bruker Corporation (BRKR) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BRKR's profitability grade?
Bruker Corporation (BRKR) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BRKR's financial strength grade?
Bruker Corporation (BRKR) earns a financial strength grade of D+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BRKR?
The average analyst price target for Bruker Corporation (BRKR) is $59.50 from 33 analysts, which is -7.0% versus the recent price of $64.00.
What is BRKR's Piotroski score?
Bruker Corporation (BRKR) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.